Compound information
- Natural Products
- ZC2228588
- Molecular Formula
- C25H39N3O5
- Molecular Weight
- 461.288971348 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S)-1-[[(1S)-1-[[(1S)-1-formylbutyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamate
- InChI
- InChI=1S/C25H39N3O5/c1-6-10-20(15-29)26-23(30)21(13-17(2)3)27-24(31)22(14-18(4)5)28-25(32)33-16-19-11-8-7-9-12-19/h7-9,11-12,15,17-18,20-22H,6,10,13-14,16H2,1-5H3,(H,26,30)(H,27,31)(H,28,32)/t20-,21-,22-/m0/s1
- InChI Key
- QEJRGURBLQWEOU-FKBYEOEOSA-N
- SMILES
- CCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1
- Source
- ZINC000014806791
Warheads
- Carbamate
-
- Aldehydic carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 33 | Ring Count | 1 |
Heteroatom Count | 8 | Rotatable Bond Count | 14 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 113.6 Å2 | LogP | 3.924 |
LogS | -3.92 | LogD | 4.458 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.987 | Pgp substrate | 0.266 |
HIA | 0.738 | F20 % | 0.989 |
F30 % | 0.169 | Caco-2 | -4.764 |
MDCK | -4.843 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.162 | PPB | 87.472 |
VD | 0.651 | Fu | 1.518 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.005 | CYP1A2 substrate | 0.707 |
CYP2A6 substrate | 0.426 | CYP2B6 substrate | 0.585 |
CYP2C19 inhibitor | 0.448 | CYP2C19 substrate | 0.977 |
CYP2C8 substrate | 0.814 | CYP2C9 inhibitor | 0.186 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.037 |
CYP2D6 substrate | 0.856 | CYP2E1 substrate | 0.206 |
CYP3A4 inhibitor | 0.183 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.863 | CL | 8.696 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.009 | Hepatotoxicity | 0.982 |
Mutagenicity | 0.138 | Rat Oral Acute Toxicity | 0.188 |
FDAMDD | 0.39 | Skin Sensitization | 0.748 |
Carcinogenicity | 0.024 | Eye Corrosion | 0.015 |
Eye Irritation | 0.018 | Respiratory Toxicity | 0.015 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.802 | IGC50 | 3.942 |
LC50FM | 4.114 | LC50DM | 5.13 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.124 | NR-AR-LBD | 0.271 |
NR-AhR | 0.005 | NR-Aromatase | 0.083 |
NR-ER | 0.373 | NR-ER-LBD | 0.34 |
NR-PPAR-gamma | 0.594 | SR-ARE | 0.593 |
SR-ATAD5 | 0.357 | SR-HSE | 0.256 |
SR-MMP | 0.258 | SR-p53 | 0.039 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.